enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors
enGene’s Board is now comprised of seven members including Richard Glickman (Chairman), Gerald Brunk, Jasper Bos, and Jason Hanson.
- enGene’s Board is now comprised of seven members including Richard Glickman (Chairman), Gerald Brunk, Jasper Bos, and Jason Hanson.
- “We are pleased to welcome Paul and Wouter to our Board of Directors.
- “The Company is well-positioned for success, and I look forward to working with the management team to execute its vision.”
Mr. Joustra said, “I’m thrilled to join enGene’s Board of Directors. - Currently Mr. Joustra serves on the board of directors of VectorY Therapeutics and holds a position as a board observer at NewAmsterdam Pharma N.V. (NASDAQ: NAMS).